NEW HOPE, Minn., December 3rd, 2024 – VitalPath, specializing in the design and manufacture of custom, highly complex catheter solutions for medical device OEMs, announced the promotion of Bridget Locke to Vice President, Strategic Marketing. The promotion aligns with VitalPath’s strategic imperatives for revenue growth and diversification as well as the company’s vision, mission, and values. In this new role, Bridget will continue to develop and execute brand strategy, with increased sales operations responsibilities to drive business growth and increase market share.
“I am continually impressed by Bridget’s unique ability to swiftly evaluate the marketing efforts of a MedTech organization and develop holistic strategic plans that achieve both internal and external objectives, driving brand awareness and significant growth,” said Rich Rivard, Chief Commercial Officer. “Her expertise in marketing and sales operations, combined with her hands-on approach and ability to relate to all functions and levels of an organization, makes Bridget a valued leader. Bridget consistently demonstrates the VitalPath mission and values through her dedication, strategic vision, and collaborative spirit, which inspires and drives our team forward.”
Bridget Locke joined the organization earlier this year as Senior Director, Strategic Marketing, bringing her MedTech industry experience in brand positioning, sales operations, targeted campaigns, content and thought leadership, website optimization, as well as corporate communications. Before VitalPath, she held key roles at several medical device CDMO’s including Vantedge Medical, Medevio, ATL Technology and Northwire. Bridget has a proven track record of developing growth strategies to align company value with customer needs to drive customer journey success, and pipeline growth.
“I am delighted to have this opportunity to continue to evolve our marketing and sales operations at VitalPath. The contributions that the VitalPath team makes to the MedTech community is truly inspiring. We have many exciting and impactful projects underway, but at the end of the day, we aim to amplify the impact of our mission to dramatically improve the quality of patient lives in partnership with our vital customers,” said Bridget Locke, Vice President of Strategic Marketing.
In addition to this notable promotion, VitalPath has recently invested in facility upgrades to foster innovation as a leading CDMO in the complex catheter space. This includes clean room investments at their Maplewood, MN catheter development and manufacturing site to increase overall capacity by 40% along with an optimized flow of product. Additionally, the clean room at VitalPath’s dedicated R&D design center in New Hope, MN was recently upgraded from a class 8 to a class 7. These facility investments paired with the company’s catheter component and laser expertise out of Cokato, MN, means strategic customer partnerships are supported with a comprehensive breadth of vertically integrated capabilities to set the stage for continued growth.
About VitalPath
VitalPath, an Inverness Graham portfolio company, has more than 300 employees at four Minneapolis area locations. Featuring ISO 7 & 8 cleanrooms, the company is ISO 13485:2016 certified with an FDA registered site. The VitalPath team specializes in meeting customers’ most challenging complex catheter requirements, such as single or multidirectional deflection, pushability, kink resistance and torque response. Serving customers in the electrophysiology, structural heart, neurovascular, peripheral vascular, left ventricular assist, intracoronary, intravascular lithotripsy and renal denervation markets, VitalPath is the culmination of three distinct catheter manufacturing companies formerly known as VitalDyne Medical, Catheter & Medical Design, and Modern Catheter Technologies.
In addition to speeding customers’ time to market through design and development, the catheter manufacturer is also uniquely positioned to consolidate supply chains with vertically integrated capabilities to bring complete complex catheters to market for vital customers. Their comprehensive suite of capabilities support complex component manufacturing with laser cutting, welding, ablation, forming and bending, catheter development and assembly with extrusion, braiding, and coiling as well as finishing and value add with tipping, flaring, swaging, laser drilling, skiving, machining, and marking.
For more information, visit https://vitalpath.com/ and follow VitalPath on LinkedIn
About Inverness Graham
Inverness Graham is a Philadelphia-based buyout firm that acquires innovative companies where technology is transforming traditional industry. The firm’s Flagship strategy focuses on high-growth businesses leveraging technology in Healthcare, Software and Advanced Manufacturing. The firm’s Green Light strategy targets technology-enabled businesses where Environmental Sustainability is a key driver of accelerating growth. Inverness Graham executes a differentiated, repeatable model for value creation through its proprietary “Strategic Platform Build” approach. Founded by senior executives of the Graham Group, the firm builds upon a 60-year legacy of operational excellence, bringing substantial value creation resources and an innovative mindset to support its portfolio company partners.
For more information, visit invernessgraham.com
